• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street

cafead

Administrator
Staff member
  • cafead   Oct 03, 2019 at 10:22: PM
via With five biotech IPOs on the calendar, this week was expected to be a big one. Three companies ended up making Wall Street debuts, raising a combined $320 million, led by Viela Bio. But two other firms didn’t like the market conditions and decided against going public for now. Here’s a recap of the week’s biotech IPO activity so far:

article source
 

<